Cédric Boudou

Cédric Boudou is an experienced project leader and entrepreneur specializing in medicinal chemistry and drug discovery. Currently, Cédric leads academic drug discovery programs at the University of Geneva, focusing on oncology and the Wnt-pathway, while securing funding and developing plans for spin-off companies. Previous roles include project leadership at AC Immune, where Cédric managed efforts against α-synucleinopathies, and independent consulting in drug discovery. With a strong background in CNS diseases at Addex Therapeutics and experience at companies like Idealp Pharma and Janssen-Cilag, Cédric has successfully overseen cross-functional teams, managed complex projects, and contributed to scientific publications. Cédric holds a PhD in Organic Chemistry from Université de Caen Normandie and a Master's degree from ENSICAEN.